INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
$4.65 0.05 (1.087%)
Analysed INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) News Sources
Insight Molecular Diagnostics Inc. Q1 2026 Earnings Call Summary
14-05-2026
moby.co
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With Fresh Capital And GraftAssureDx Submission
15-05-2026
yahoo.com
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
09-06-2026
yahoo.com
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
11-06-2026
yahoo.com
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
16-06-2026
yahoo.com
Breakthrough Science Meets Market Skepticism: Insight Molecular Diagnostics Inc. (IMDX)’s Defining Moment
19-06-2026
yahoo.com
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
22-06-2026
yahoo.com
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
29-06-2026
yahoo.com
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
16-07-2026
yahoo.com
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
23-07-2026
yahoo.com
What is the current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is $4.65.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is $0.05.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is 1.087%.
What is the most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is .
SEC-8K** Filing Available For INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.